GeneCentric Therapeutics, Inc. research brief
CIK 1529224
Generated Nov. 18, 2026, 8:15 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: DURHAM North Carolina. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- June 20, 2025 · D · 0001529224-25-000001 · Source evidence
Reported offering amount: 5000000 USD. Reported amount sold: 1999967 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “GeneCentric Therapeutics, Inc. research brief,” CIK 1529224, retrieved Nov. 18, 2026, 8:15 a.m.. Cite the specific accessions used. No amounts have been summed.